Connection

Jordan Elm to Stroke

Back to Details
This is a "connection" page, showing publications Jordan Elm has written about Stroke.
Jordan Elm
Connection Strength
1.949
Stroke
  1. Evolution of the Modified Rankin Scale and Its Use in Future Stroke Trials. Stroke. 2017 07; 48(7):2007-2012.
    View in: PubMed
    Score: 0.238
  2. Transcranial Direct-Current Stimulation in Subacute Aphasia: A Randomized Controlled Trial. Stroke. 2023 Apr; 54(4):912-920.
    View in: PubMed
    Score: 0.089
  3. Cilostazol for Secondary Stroke Prevention: History, Evidence, Limitations, and Possibilities. Stroke. 2021 10; 52(10):e635-e645.
    View in: PubMed
    Score: 0.080
  4. Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial. Int J Stroke. 2022 08; 17(7):806-809.
    View in: PubMed
    Score: 0.080
  5. The Utility of Domain-Specific End Points in Acute Stroke Trials. Stroke. 2021 03; 52(3):1154-1161.
    View in: PubMed
    Score: 0.077
  6. The multiarm optimization of stroke thrombolysis phase 3 acute stroke randomized clinical trial: Rationale and methods. Int J Stroke. 2021 10; 16(7):873-880.
    View in: PubMed
    Score: 0.076
  7. National Institutes of Health StrokeNet During the Time of COVID-19 and Beyond. Stroke. 2020 08; 51(8):2580-2586.
    View in: PubMed
    Score: 0.073
  8. Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial. Stroke. 2020 07; 51(7):2058-2065.
    View in: PubMed
    Score: 0.073
  9. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial. Stroke. 2020 03; 51(3):792-799.
    View in: PubMed
    Score: 0.072
  10. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. JAMA Netw Open. 2019 09 04; 2(9):e1910769.
    View in: PubMed
    Score: 0.069
  11. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. JAMA Neurol. 2019 07 01; 76(7):774-782.
    View in: PubMed
    Score: 0.069
  12. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Circulation. 2019 08 20; 140(8):658-664.
    View in: PubMed
    Score: 0.069
  13. Factors Influencing Oral Intake Improvement and Feeding Tube Dependency in Patients with Poststroke Dysphagia. J Stroke Cerebrovasc Dis. 2019 Jun; 28(6):1421-1430.
    View in: PubMed
    Score: 0.067
  14. Mapping acute lesion locations to physiological swallow impairments after stroke. Neuroimage Clin. 2019; 22:101685.
    View in: PubMed
    Score: 0.067
  15. Transcranial Direct Current Stimulation vs Sham Stimulation to Treat Aphasia After Stroke: A Randomized Clinical Trial. JAMA Neurol. 2018 12 01; 75(12):1470-1476.
    View in: PubMed
    Score: 0.066
  16. Effect of IV glyburide on adjudicated edema endpoints in the GAMES-RP Trial. Neurology. 2018 12 04; 91(23):e2163-e2169.
    View in: PubMed
    Score: 0.066
  17. Cardioembolic Stroke Risk and Recovery After Anticoagulation-Related Intracerebral Hemorrhage. Stroke. 2018 11; 49(11):2652-2658.
    View in: PubMed
    Score: 0.065
  18. Long-Term Outcomes in Patients Aged =70 Years With Intravenous Glyburide From the Phase II GAMES-RP Study of Large Hemispheric Infarction: An Exploratory Analysis. Stroke. 2018 06; 49(6):1457-1463.
    View in: PubMed
    Score: 0.063
  19. Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med. 2018 Jul 19; 379(3):215-225.
    View in: PubMed
    Score: 0.063
  20. Differences in swallow physiology in patients with left and right hemispheric strokes. Physiol Behav. 2018 10 01; 194:144-152.
    View in: PubMed
    Score: 0.063
  21. Oral Anticoagulation and Functional Outcome after Intracerebral Hemorrhage. Ann Neurol. 2017 Nov; 82(5):755-765.
    View in: PubMed
    Score: 0.061
  22. Human Data Supporting Glyburide in Ischemic Stroke. Acta Neurochir Suppl. 2016; 121:13-8.
    View in: PubMed
    Score: 0.054
  23. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale. Stroke. 2015 Aug; 46(8):2238-43.
    View in: PubMed
    Score: 0.052
  24. Glyburide is associated with attenuated vasogenic edema in stroke patients. Neurocrit Care. 2014 Apr; 20(2):193-201.
    View in: PubMed
    Score: 0.048
  25. Pilot study of intravenous glyburide in patients with a large ischemic stroke. Stroke. 2014 Jan; 45(1):281-3.
    View in: PubMed
    Score: 0.046
  26. Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug; 8(6):479-83.
    View in: PubMed
    Score: 0.046
  27. Validating imaging biomarkers of cerebral edema in patients with severe ischemic stroke. J Stroke Cerebrovasc Dis. 2013 Aug; 22(6):742-9.
    View in: PubMed
    Score: 0.041
  28. BDNF genotype and tDCS interaction in aphasia treatment. Brain Stimul. 2018 Nov - Dec; 11(6):1276-1281.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.